EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice

Ryszard Międzybrodzki iD, Hubert Kasprzak, Sławomir Letkiewicz, Paweł Rogóż, Maciej Żaczek, Jamon Thomas, Andrzej Górski

Clinical Infectious Diseases · 02.11.2023 · 77 (Supplement_5) · S395-S400

DOI: 10.1093/cid/ciad516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.11.2023. Verfasst von Ryszard Międzybrodzki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland. Hauptthemen laut MEDLINE: Phage Therapy, Bacterial Infections, Bacteriophages. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteriophages present unique features that enable targeted killing of bacteria, including strains resistant to many antibiotics. However, phage pharmacokinetics and pharmacodynamics constitute much more complex and challenging aspects for researchers than those attributable to antibiotics. This is because phages are not just chemical substances, but also biological nanostructures built of different proteins and genetic material that replicate within their bacterial hosts and may induce immune responses acting as simple antigens. Here, we present a few examples of how primary general assumptions on phage pharmacokinetics and pharmacodynamics are verified by current preclinical and clinical observations, leading to conclusions that may not be obvious at first but are of significant value for the final success of phage therapy in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyBacterial InfectionsBacteriophagesHumansBacteriaAnti-Bacterial Agents

Stichwörter der Autor:innen

bacteriophagesphage therapypharmacodynamicspharmacokinetics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
  • Phage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
  • Department of Clinical Immunology, Medical University of Warsaw, Poland.
  • Collegium Medicum, Jan Długosz University, Częstochowa, Poland.
  • Clinic of Immunology, Transplantology and Internal Medicine, Infant Jesus Hospital, Medical University of Warsaw, Poland.

ORCID-Profile: Ryszard Międzybrodzki

Zitieren

APA

Międzybrodzki, R., Kasprzak, H., Letkiewicz, S., Rogóż, P., Żaczek, M., Thomas, J., & Górski, A. (2023). Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice. Clinical Infectious Diseases, 77(Supplement_5), S395-S400. https://doi.org/10.1093/cid/ciad516

Vancouver

Międzybrodzki R, Kasprzak H, Letkiewicz S, Rogóż P, Żaczek M, Thomas J, et al. Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice. Clinical Infectious Diseases. 2023;77(Supplement_5):S395-S400. doi:10.1093/cid/ciad516

BibTeX
@article{Midzybrodzki2023,
  author = {Międzybrodzki, Ryszard and Kasprzak, Hubert and Letkiewicz, Sławomir and Rogóż, Paweł and Żaczek, Maciej and Thomas, Jamon and Górski, Andrzej},
  title = {Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {77},
  number = {Supplement_5},
  pages = {S395--S400},
  doi = {10.1093/cid/ciad516}
}
Kostenlos starten →